SB164 expands and clarifies Colorado law governing opioid antagonists, such as naloxone, with a particular emphasis on youth overdose prevention. The bill directs the Colorado Youth Advisory Council to present twice a year to the State Board of Health on the youth opioid epidemic and other health issues, and requires the council to consult with the Prevention Services Division during rulemaking on opioid antagonists. It also requires the State Board of Health to allow the council to present twice yearly on these topics.
The bill makes several changes to school opioid-antagonist policies. It clarifies that schools may keep opioid antagonists in automated external defibrillator or defibrillator cabinets, and it expands when school employees or agents may administer or furnish an opioid antagonist to a student, including in circumstances where the student has not received school-sponsored training but is in a position to help someone experiencing an overdose. The bill also creates a State Board of Health eligible-entity list for entities that may be prescribed or dispensed opioid antagonists, and authorizes the chief medical officer to issue a standing order allowing those listed entities to distribute them.
SB164 further updates related statutes to align with the new eligible-entity framework. It amends existing prescribing, dispensing, immunity, and safe-disposal provisions so that entities on the new State Board of Health list are covered, including schools, local governments, libraries, community organizations, religious organizations, jails, correctional facilities, probation and pretrial services, local public health agencies, higher education institutions, and mental health professionals. It also adds annual reporting to the legislature beginning in January 2026 on youth overdose prevention as part of the department’s SMART Act presentation.
The bill’s overall impact is to broaden access to opioid antagonists, reduce legal uncertainty for schools and other organizations, and strengthen youth-focused overdose prevention policy. It also provides liability and prosecution protections for eligible entities acting under the law, including protection for possession of controlled substances for safe disposal in the course of their duties.
The sentiment around the bill appears strongly supportive. Committee votes were unanimous on the Senate side for amendments and committee referral, and the bill advanced through both chambers with overwhelming floor support, including a 32-2 Senate third reading vote and a 61-1 House third reading vote. That voting pattern suggests broad bipartisan agreement on the need to expand naloxone access and youth overdose prevention measures.
There is little evidence of major controversy in the available record, but the main policy issues are the scope of school authority and the breadth of the eligible-entity list. The bill gives schools more flexibility to store and administer opioid antagonists and extends protections to a wide range of entities, which could raise questions about implementation, training, and oversight. The youth advisory council’s role in health policy and rulemaking is another notable feature, though the votes suggest these provisions were not significantly contested.
SB164 amends multiple sections of Colorado law to create a new State Board of Health eligible-entity framework for opioid antagonists, update school policy provisions, and align immunity and safe-disposal statutes with the expanded distribution system. It affects statutes governing school possession and administration of opioid antagonists, prescriber authority, civil and criminal immunity, and controlled-substance possession for safe disposal, while also requiring annual youth overdose prevention reporting and regular consultation with the Colorado Youth Advisory Council.
The bill appears to have received broadly favorable treatment throughout the legislative process. Committee actions were unanimous or near-unanimous, and final passage votes in both chambers were overwhelmingly in favor. The available record suggests a general consensus that expanding naloxone access and focusing on youth overdose prevention are important public health measures.
No major opposition is reflected in the available transcripts or vote history, but the bill’s most likely points of contention are policy scope and implementation. These include allowing schools to store opioid antagonists in AED cabinets, permitting broader administration and furnishing authority in school settings, and creating a broad eligible-entity list that covers many public, private, and correctional institutions. Questions could also arise about training requirements, school discretion, and how the State Board of Health will manage the new list and related rulemaking.